Concepedia

Martin Heuschkel

MH

7

Publications

1K

Citations

7

H-Index

2016

Active since

Affiliations

University of Rostock(Current)

Martin Heuschkel is an author at University of Rostock specializing in radiation oncology, medicine, and oncology.

Top concepts

Publications per year

2016–2023

7

Publications

7

German Multicenter Study Investigating<sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil et al. · Journal of Nuclear Medicine · 2016 · 812 citations · Full text

First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer

Jens Kurth, Bernd J. Krause, Sarah M. Schwarzenböck et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 136 citations

, , +6

Streamlined Schemes for Dosimetry of 177Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer

Jens Kurth, Martin Heuschkel, Alexander Tonn et al. · Cancers · 2021 · 26 citations · Full text

, , +14

Peptide receptor radionuclide therapy with 177Lu-DOTA-octreotate

Anastassia Löser, Sarah M. Schwarzenböck, Martin Heuschkel et al. · Nuclear Medicine Communications · 2018 · 23 citations

Preclinical Comparison of the<sup>64</sup>Cu- and<sup>68</sup>Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [<sup>68</sup>Ga]Ga-AMTG PET/CT

Lena Koller, Markus Joksch, Sarah M. Schwarzenböck et al. · Journal of Nuclear Medicine · 2023 · 21 citations · Full text

Rows per page

1–5 of 7